An antagonist of MCH1
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SNAP 94847

Item No. 35105

Technical Information
Formal Name
N-[3-[1-[[4-(3,4-difluorophenoxy)phenyl]methyl]-4-piperidinyl]-4-methylphenyl]-2-methyl-propanamide
CAS Number
487051-12-7
Molecular Formula
C29H32F2N2O2
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: insolDMSO: 25 mg/mlEthanol: 10 mg/mlPBS (pH 7.2): insol
λmax
236 nm
SMILES
O=C(C(C)C)NC1=CC=C(C)C(C2CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C(F)=C4)F)=C1
InChi Code
InChI=1S/C29H32F2N2O2/c1-19(2)29(34)32-23-7-4-20(3)26(16-23)22-12-14-33(15-13-22)18-21-5-8-24(9-6-21)35-25-10-11-27(30)28(31)17-25/h4-11,16-17,19,22H,12-15,18H2,1-3H3,(H,32,34)
InChi Key
VMLZFUVIKCGATC-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    SNAP 94847 is an antagonist of melanin-concentrating hormone receptor 1 (MHC1; Ki = 2.2 nM for the recombinant rat receptor).1 It is selective for MHC1 over α1A-adrenergic and dopamine D2 receptors (Kis = 180 and 7,400 nM, respectively, for the recombinant human receptors). SNAP 94847 (20 mg/kg) increases the time mice spend in the light side of the light/dark exploration test, indicating anxiolytic-like activity.2 It reduces food intake and body weight, as well as plasma levels of glucose, insulin, and triglycerides, in a mouse model of high-fat diet-induced obesity when administered at a dose of 5 mg/kg in combination with the cannabinoid 1 (CB1) receptor antagonist rimonabant (Item No. 9000484).3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chen, C.-A., Jiang, Y., Lu, K., et alSynthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hits. J. Med. Chem. 50(16), 3883-3890 (2007).

    2. David, D.J., Klemenhagen, K.C., Holick, K.A., et alEfficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J. Pharmacol. Exp. Ther. 321(1), 237-248 (2007).

    3. Verty, A.N.A., Lockie, S.H., Stefanidis, A., et alAnti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice. Int. J. Obes. (Lond) 37(2), 279-287 (2013).